Literature DB >> 7534414

Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.

T Taniguchi1, M J Sullivan, O Ogawa, A E Reeve.   

Abstract

In most tissues IGF2 is expressed from the paternal allele while H19 is expressed from the maternal allele. We have previously shown that in some Wilms tumors the maternal IGF2 imprint is relaxed such that the gene is expressed biallelically. We have now investigated this subset of tumors further and found that biallelic expression of IGF2 was associated with undetectable or very low levels of H19 expression. The relaxation of IGF2 imprinting in Wilms tumors also involved a concomitant reversal in the patterns of DNA methylation of the maternally inherited IGF2 and H19 alleles. Furthermore, the only specific methylation changes that occurred in tumors with relaxation of IGF2 imprinting were solely restricted to the maternal IGF2 and H19 alleles. These data suggest that there has been an acquisition of a paternal epigenotype in these tumors as the result of a pathologic disruption in the normal imprinting of the IGF2 and H19 genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534414      PMCID: PMC42443          DOI: 10.1073/pnas.92.6.2159

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  DNA methylation and gene activity.

Authors:  H Cedar
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

2.  Reduced genomic 5-methylcytosine content in human colonic neoplasia.

Authors:  A P Feinberg; C W Gehrke; K C Kuo; M Ehrlich
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

3.  Epigenetic lesions at the H19 locus in Wilms' tumour patients.

Authors:  T Moulton; T Crenshaw; Y Hao; J Moosikasuwan; N Lin; F Dembitzer; T Hensle; L Weiss; L McMorrow; T Loew; W Kraus; W Gerald; B Tycko
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

4.  Isolation of a transforming sequence from a human bladder carcinoma cell line.

Authors:  C Shih; R A Weinberg
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

5.  The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia.

Authors:  A de Bustros; B D Nelkin; A Silverman; G Ehrlich; B Poiesz; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Sequence of a cDNA clone encoding human preproinsulin-like growth factor II.

Authors:  G I Bell; J P Merryweather; R Sanchez-Pescador; M M Stempien; L Priestley; J Scott; L B Rall
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

7.  The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA.

Authors:  R M Lawn; E F Fritsch; R C Parker; G Blake; T Maniatis
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

8.  Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous.

Authors:  G I Bell; D S Gerhard; N M Fong; R Sanchez-Pescador; L B Rall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Expression of insulin-like growth factor-II transcripts in Wilms' tumour.

Authors:  A E Reeve; M R Eccles; R J Wilkins; G I Bell; L J Millow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

10.  Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues.

Authors:  J Scott; J Cowell; M E Robertson; L M Priestley; R Wadey; B Hopkins; J Pritchard; G I Bell; L B Rall; C F Graham
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

View more
  38 in total

Review 1.  Epigenetic gene silencing in cancer.

Authors:  B Tycko
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.

Authors:  W Hartmann; A Waha; A Koch; C G Goodyer; S Albrecht; D von Schweinitz; T Pietsch
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  The product of the imprinted H19 gene is an oncofetal RNA.

Authors:  I Ariel; S Ayesh; E J Perlman; G Pizov; V Tanos; T Schneider; V A Erdmann; D Podeh; D Komitowski; A S Quasem; N de Groot; A Hochberg
Journal:  Mol Pathol       Date:  1997-02

Review 4.  Genomic imprinting and cancer.

Authors:  J A Joyce; P N Schofield
Journal:  Mol Pathol       Date:  1998-08

5.  bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA.

Authors:  W Tam; D Ben-Yehuda; W S Hayward
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  ISWI contributes to ArsI insulator function in development of the sea urchin.

Authors:  Mamiko Yajima; William G Fairbrother; Gary M Wessel
Journal:  Development       Date:  2012-10       Impact factor: 6.868

7.  The prevalence of loss of imprinting of H19 and IGF2 at birth.

Authors:  Rebecca C Rancourt; Holly R Harris; Ludovic Barault; Karin B Michels
Journal:  FASEB J       Date:  2013-04-25       Impact factor: 5.191

8.  H19 expression in hepatic metastases from a range of human carcinomas.

Authors:  Y Fellig; I Ariel; P Ohana; P Schachter; I Sinelnikov; T Birman; S Ayesh; T Schneider; N de Groot; A Czerniak; A Hochberg
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

9.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.

Authors:  I Ariel; H Q Miao; X R Ji; T Schneider; D Roll; N de Groot; A Hochberg; S Ayesh
Journal:  Mol Pathol       Date:  1998-02

10.  Evaluation of allelic expression of imprinted genes in adult human blood.

Authors:  Jennifer M Frost; Dave Monk; Taita Stojilkovic-Mikic; Kathryn Woodfine; Lyn S Chitty; Adele Murrell; Philip Stanier; Gudrun E Moore
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.